Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the same period
Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results
Categories
Health Care
Ocean Biomedical shares details of its successful lung cancer program on World Lung Cancer Day
Biopharmaceutical company Ocean Biomedical, Inc. (NASDAQ: OCEA) provided details of its multi-pronged lung cancer program built on novel immunotherapy discoveries by the
PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results
Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net income declined
Centene Corporation (CNC) Q2 2023 Earnings Summary
Centene Corporation (NYSE: CNC) reported second quarter 2023 earnings results today. Total revenues amounted to $37.6 billion compared to $35.9 billion in
BSX Earnings: Highlights of Boston Scientific’s Q2 2023 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the second quarter of 2023. The company also provided guidance for
BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall in revenues.
AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today. Worldwide net revenues were $13.8 billion, down 4.9% on a reported basis,
BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023. Total
Infographic: Thermo Fisher Scientific (TMO) Q2 2023 Earnings Results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter 2023 earnings results today. Revenue declined 3% to $10.69 billion compared to the
Intuitive Surgical (ISRG) reports higher Q2 revenues and earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues and adjusted
Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today. Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net
Novartis AG (NVS) Q2 2023 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah -- Global Head, Investor Relations Vasant (Vas) Narasimhan -- Chief
A look at the factors that influenced UnitedHealth’s Q2 earnings
Health insurance company UnitedHealth Group (NYSE: UNH) reported strong second-quarter results last week, triggering a stock rally. The company also strengthened its
UnitedHealth Group Incorporated (UNH) Q2 2023 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- Chief Operating
Organigram Holdings Inc (OGI) Q3 2023 Earnings Call Transcript
Organigram Holdings Inc (NASDAQ: OGI) Q3 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations Beena Goldenberg -- Chief
Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move is part
Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings
Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company also raised
Theratechnologies Inc (THTX) Q2 2023 Earnings Call Transcript
Theratechnologies Inc (NASDAQ: THTX) Q2 2023 earnings call dated Jul. 12, 2023 Corporate Participants: John Mullaly -- Managing Director, LifeSci Advisors, LLC Paul Levesque -- President
Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief Financial Officer
Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided